Agustin Agustin, Yanti Hermayanti, Ida Maryati, Henny Suzanna Mediani


Every woman is at risk for ovarian cancer. Until now, ovarian cancer is the 3rd of the 10 most common cancers in women. If exposed, it can cause complex problems until death occurs. For that every woman needs to be aware of this disease by recognizing the risk factors. The purpose of this study is to explore these various factors through a review of related literature through searches of thedatabases Pubmed, Science Direct, Willey, and Cambrige with a total of 10 analysis articles originating from America, China, Taiwan, Europe, Alaska, England and Finland. By searching for articles according to the inclusion criteria, namely full text, published in 2010 - 2020, articles having DOIs, experimental research designs and case studies, using the keywords risk factor and ovarian cancer. The results obtained 602 articles, and 10 articles describing the incidence of ovarian cancer were proven to be related to an imbalance of FSH, estrogen and progesterone hormones, the use of cosmetic products on the face and genetalia containing asbestos, and a family history of cancer. Based on these results, women should immediately get checked out if there are hormonal disorders such as disrupted menstrual cycles, and not use cosmetic products that contain asbestos, and observe symptoms from an early age if the family has had ovarian cancer or breast cancer. Conclusion: by knowing the risk factors, each woman can assess the risk factors that are present in her, so that she can do early detection of ovarian cancer and immediately get therapy if ovarian cancer is found quickly and precisely This research can be continued by focusing more research on factors of hormonal and non-hormonal contraceptive use.



Ovarian cancer detection, risk factors, ovarian cancer.

Full Text:



Bacalbasa, N., Balescu, I., Vilcu, M., Dima, S., Diaconu, C., Iliescu, L., . . . Brezean, I. (2020). The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer. Medicina (Kaunas), 56(3). Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/32138225. doi:10.3390/medicina56030108

Huang, T., Townsend, M. K., Wentzensen, N., Trabert, B., White, E., Arslan, A. A., . . . Tworoger, S. S. (2020). Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3). Cancer Epidemiol Biomarkers Prev, 29(1), 200-207. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31719062. doi:10.1158/1055-9965.EPI-19-0734

Irvin, S. R., Weiderpass, E., Stanczyk, F. Z., Brinton, L. A., Trabert, B., Langseth, H., & Wentzensen, N. (2020). Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank. Cancer Epidemiol Biomarkers Prev, 29(3), 636-642. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31932414. doi:10.1158/1055-9965.EPI-19-0675

Kotsopoulos, J., Terry, K. L., Poole, E. M., Rosner, B., Murphy, M. A., Hecht, J. L., . . . Tworoger, S. S. (2013). Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer, 133(3), 730-739. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23364849. doi:10.1002/ijc.28064

Madiuw, D., Hermayanti, Y., & Solehati, T. (2020). CANCER RISK ASSESSMENT INSTRUMENTS IN WOMEN: LITERATURE REVIEW. Journal of Maternity Care and Reproductive Health, 3(3).

O'Brien, K. M., Tworoger, S. S., Harris, H. R., Anderson, G. L., Weinberg, C. R., Trabert, B., . . . Wentzensen, N. (2020). Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. JAMA, 323(1), 49-59. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31910280. doi:10.1001/jama.2019.20079

Qin, X., Ma, L., Yang, S., Zhao, J., Chen, S., Xie, Y., . . . Qin, A. (2014). The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis. Journals Assist Reprod Genet, 38-46.

Soini, T., Hurskainen, R., Grenman, S., Maenpaa, J., Paavonen, J., & Pukkala, E. (2016). Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube. Acta Oncol, 55(11), 1281-1284. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27148621. doi:10.1080/0284186X.2016.1175660

Steffen, J. E., Tran, T., Yimam, M., Clancy, K. M., Bird, T. B., Rigler, M., . . . Egilman, D. S. (2020). Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders-A Case Series. J Occup Environ Med, 62(2), e65-e77. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31868762. doi:10.1097/JOM.0000000000001800

Udomsinkul, P., Triratanachart, S., & Oranratanaphan, S. (2020). Risk factors for endometriotic-cyst associated ovarian cancer: A case controlled study. Taiwan J Obstet Gynecol, 59(2), 269-274. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/32127149. doi:10.1016/j.tjog.2020.01.016

Zeleznik, O. A., Eliassen, A. H., Kraft, P., Poole, E. M., Rosner, B. A., Jeanfavre, S., . . . Tworoger, S. S. (2020). A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk. Cancer Res, 80(6), 1357-1367. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/31969373. doi:10.1158/0008-5472.CAN-19-2567

DOI: https://doi.org/10.36780/jmcrh.v4i1.150


  • There are currently no refbacks.

Copyright (c) 2021 Journal of Maternity Care and Reproductive Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This Journal is indexed on:

Redaksi Journal of Maternity Care and Reproductive Health:

Fakultas Keperawatan, Universitas Padjadjaran
Jalan Raya Bandung-Sumedang Km. 21 Jatinangor, Sumedang, Indonesia 45363
WA: 081321793280
Email: admin@mcrhjournal.or..id

Creative Commons License
JMCRH is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License